3-Chloro-2-methyl-n-(4-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)thiazol-2-yl)benzenesulfonamide
| Title | Journal |
|---|---|
| BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice. | PloS one 20120101 |
| Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity. | Endocrine journal 20110101 |
| [Mechanism of BVT.2733 and pioglitazone in the improvement of insulin resistance]. | Zhonghua nei ke za zhi 20081101 |
| Blockade of glucocorticoid excess at the tissue level: inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes. | Journal of medicinal chemistry 20080828 |
| Discovery of potent and selective inhibitors of 11beta-HSD1 for the treatment of metabolic syndrome. | Bioorganic & medicinal chemistry letters 20061215 |
| Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice. | Diabetologia 20060601 |
| Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. | Endocrinology 20031101 |
| Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. | Diabetologia 20021101 |